InvestorsHub Logo

sunspotter

11/06/22 2:47 PM

#394667 RE: Blue Fin #394665

In the entirely theoretical event that the spray became available, I suspect the fact that most patients would develop either hypertension and peripheral neuropathy or both would make it a tough sell either prophylactically or for early treatment.